In this study, we found that comutation of the DDR-related genes TP53 and ATM, regardless of the EGFR mutation and status of other DDR-related genes, was associated with a higher TMB and an improved response to ICIs in patients with NSCLC. This evidence concerns the gene TP53 and non-small cell lung carcinoma.